268 results on '"Cawthorne, M. A."'
Search Results
2. ANTI-OBESITY, ANTI-DIABETIC AND ANTI-INFLAMMATORY EFFECTS OF TETRAHYDROCANNABIVARIN (THCV) IN HIGH FAT DIET-INDUCED OBESE C57BL/6 FEMALE MICE: 504 accepted poster
3. COMPARISON OF THE PHYSIOLOGICAL EFFECTS OF ZINC-2-GLYCOPROTEIN AND THE 3-ADRENOCEPTOR AGONIST, BRL35135, IN MALE C57BL6 OB/OB MICE: 418 accepted poster
4. A new, highly selective murine peroxisome proliferator-activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice
5. The new adipokine chemerin is genetically regulated and promotes angiogenesis: T1:OS2.3
6. Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and β2-adrenoceptor mechanisms
7. Metabolic programming: can it be manipulated?
8. Rational identification of prognostic markers of breast cancer
9. Opportunities and challenges for the development of pharmacological therapies for obesity treatment
10. Leptin supplementation in early life programmes muscle metabolism: OP0015
11. Prolonged treatment of genetically obese mice with conjugated linoleic acid (CLA) improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation: O103
12. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone
13. Modulation of susceptibility to weight gain and insulin resistance in low birthweight rats by treatment of their mothers with leptin during pregnancy and lactation
14. Evaluation of inhibitory guanine nucleotide regulatory protein Gi function in hepatocyte and liver membranes from obese Zucker (fa/fa) rats and their lean (Fa/?) littermates
15. Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle
16. The use of animal models in the detection and evaluation of compounds for the treatment of obesity
17. The determination of alpha-adrenergic receptor concentration on rat pancreatic islet cells
18. Circulating levels of the cytokines IL10, IFNγ and resistin in an obese mouse model of developmental programming
19. The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
20. Leanness in postnatally nutritionally programmed rats is associated with increased sensitivity to leptin and a melanocortin receptor agonist and decreased sensitivity to neuropeptide Y
21. ChemInform Abstract: Non Thiazolidinedione Antihyperglycaemic Agents. Part 1. α- Heteroatom Substituted β-Phenylpropanoic Acids.
22. The Effects of Ppar Delta and Alpha Agonist on Fatty Acid and Glucose Metabolism in Vivo and in Mouse Isolated Soleus Muscle
23. Free-tip-rotor wind-tunnel test results
24. P1-109 Patterns of postnatal growth impact on the early life programming of energy balance
25. Modulation of susceptibility to weight gain and insulin resistance in low birthweight rats by treatment of their mothers with leptin during pregnancy and lactation
26. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion
27. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling
28. Changes in plasma β-cell tropin concentrations during pregnancy in rats
29. Treatment with the Thiazolidinedione (BRL 49653) Decreases Insulin Resistance in Obese Zucker Hindlimb
30. The β-adrenoceptor selectivity profile of BRL 37344 in the pithed rat
31. β-Cell tropin- and glucose-induced hypersecretion of insulin and amylin from perfused fatty rat pancreas
32. Metabolic responses to BRL37344 and clenbuterol in soleus muscle and C2C12 cells via different atypical pharmacologies and beta2-adrenoceptor mechanisms.
33. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/farats.
34. The tissue distribution of the human β3-adrenoceptor studied using a monoclonal antibody: Direct evidence of the β3-adrenoceptor in human adipose tissue, atrium and skeletal muscle.
35. Improved glycemic control in C57Bl/KsJ (db/db) mice after treatment with the thermogenic beta-adrenoceptor agonist, BRL 26830.
36. Peripheral metabolic actions of leptin.
37. Does brown adipose tissue have a role to play in glucose homeostasis?
38. Fatty Acid Synthesis in Mice during the 24hr Cycle and during Meal-Feeding.
39. The effects of 1-alkylimidazoles on hepatic drug-metabolizing enzyme activity.
40. Vitamin E and hepatotoxic agents.
41. Vitamin E and hepatotoxic agents.
42. Vitamin E and hepatotoxic agents.
43. Effects of protein and vitamin E on haemoglobin formation in rats.
44. Measurements of lipid peroxidation and ??-tocopherol destruction in vitro and in vivo and their significance in connexion with the biological function of vitamin E.
45. Vitamin E and stress.
46. On the relationship between vitamin A and vitamin E in the rat.
47. On the postulated peroxidation of unsaturated lipids in the tissues of vitamin E-deficient rats.
48. Vitamin E and stress.
49. Vitamin E and stress.
50. Vitamin E and stress.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.